EAPC Premium Access

Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)

Event: ESC Preventive Cardiology 2021
Topic: Risk Factors and Prevention
Session type: Symposium
Date: 16 April 2021
Time: 15:15 - 16:20

Session

Become an EAPC member to access this resource

Become a member

Already a member? Sign in

8 presentations in this session

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction

Speaker: Mr G. Neif Vieira Musse (Sao Paulo, BR)
Thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary

Speaker: Professor M. Minicucci (Botucatu, BR)
Thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion

Thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Speaker: Doctor C. Ballantyne (Houston, US)
Thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.

Speaker: Professor U. Landmesser (Berlin, DE)
Thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

Thumbnail

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers

Speaker: Professor R. Sarzani (Ancona, IT)
Thumbnail

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers - Discussion

Thumbnail

5 speakers from this session

Mr Guilherme Neif Vieira Musse

Paulista State University (UNESP), Sao Paulo (Brazil)
1 presentation
0 follower

Professor Marcos Minicucci

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)
1 presentation
0 follower

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
34 presentations
1 follower

Professor Riccardo Sarzani

Marche Polytechnic University of Ancona, Ancona (Italy)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk